Dr. Reddy’s receives DCGI approval to conduct phase 2/3 trials of the Sputnik V vaccine in India Dr. Reddy’s Laboratories (DRL) has received regulatory approval from the Drugs Controller General of India (DCGI) to conduct mid-to-late-stage human trials for Russia’s Sputnik V vaccine candidate in India. The developments bring India a step closer to potentially getting a Covid-19 vaccine by...